Limited (LTD) Stage Small Cell Lung Cancer (SCLC) treated with concurrent BID chest radiotherapy (RT) and etoposide cisplatin (VP/PT) followed by chemotherapy (CT) selected by in vitro Drug Sensitivity Testing (DST): B.E. Johnson, C. Salem, J. Nesbitt, A.F. Gazdar, M. Lesar, R. Phelps, M. Edison, R.I. Linnolla, J. Phares, H. Pass, J. Mulshine, J.D. Minna, E. Glatstein, D.C. Ihde. NCI-Navy Med., Rad. Oncol. and Surg. Br, NCI, Surg. and Rad. Dep., Nav. Hosp. and USUHS, Bethesda, MD 20889-5105